PharmaCyte Biotech, Inc. (PMCB) › Shares OutstandingPharmaCyte Biotech, Inc. (PMCB) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2012: 416.29M2013: 482.11M2014: 690.62M2015: 732.76M2016: 781.23M2017: 905.35M2018: 1.01B2019: 1.19B2020: 1.09M2021: 1.59M2022: 20.72M2023: 16.79M2024: 8.04M2025: 6.80M6.80M2012Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY20256.80M-15.5%20248.04M-52.1%202316.79M-19.0%202220.72M+1203.1%20211.59M+45.6%20201.09M-99.9%20191.19B+17.0%20181.01B+11.9%2017905.35M+15.9%2016781.23M+6.6%2015732.76M+6.1%2014690.62M+43.2%2013482.11M+15.8%2012416.29M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share